Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2007-11-01 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE MEE-SUR-SEINE (77350), Seine-et-Marne
PHARMACIE DES MIMOSAS : revenue, balance sheet and financial ratios
PHARMACIE DES MIMOSAS is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE MEE-SUR-SEINE (77350),
this company of category PME
shows in 2014 a revenue of 2.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES MIMOSAS (SIREN 500659065)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
2 208 343 €
2 354 155 €
Net income
-129 990 €
4 916 €
44 907 €
187 602 €
75 961 €
114 282 €
159 391 €
91 429 €
130 692 €
71 728 €
34 885 €
126 177 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
217 608 €
264 143 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1.6%
5.4%
Revenue and income statement
In 2024, PHARMACIE DES MIMOSAS records a net loss of 130 k€. This deficit will reduce equity on the balance sheet.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-129 990 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 79%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
79.3%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
51.348%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES MIMOSAS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
162.468
176.455
138.327
110.587
110.95
86.974
70.973
104.208
88.654
84.225
68.237
79.3
Financial autonomy
33.456
32.458
37.53
41.837
42.227
47.081
53.142
44.535
48.89
50.953
56.279
51.348
Repayment capacity
7.229
21.954
None
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
5.941%
2.352%
None%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
79.32024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of PHARMACIE DES MIMOSAS (79.30) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
51.35%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good
In 2024, the financial autonomy of PHARMACIE DES MIMOSAS (51.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 207.14. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
207.138
Liquidity indicators evolution PHARMACIE DES MIMOSAS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
121.35
190.502
163.957
184.651
189.936
192.532
205.559
387.847
413.869
516.189
447.895
207.138
Interest coverage
18.436
70.228
None
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
207.142024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good-17 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DES MIMOSAS (207.14) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DES MIMOSAS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
188 356 €
245 413 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
21
22
0
0
0
0
0
0
0
0
0
0
Customer payment term (days)
4
5
0
0
0
0
0
0
0
0
0
0
Supplier payment term (days)
34
33
0
0
0
0
0
0
0
0
0
0
Positioning of PHARMACIE DES MIMOSAS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES MIMOSAS with other companies in the same sector:
Frequently asked questions about PHARMACIE DES MIMOSAS
What is the revenue of PHARMACIE DES MIMOSAS ?
The revenue of PHARMACIE DES MIMOSAS in 2014 is 2.2 M€.
Is PHARMACIE DES MIMOSAS profitable?
PHARMACIE DES MIMOSAS recorded a net loss in 2024.
Where is the headquarters of PHARMACIE DES MIMOSAS ?
The headquarters of PHARMACIE DES MIMOSAS is located in LE MEE-SUR-SEINE (77350), in the department Seine-et-Marne.
Where to find the tax return of PHARMACIE DES MIMOSAS ?
The tax return of PHARMACIE DES MIMOSAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES MIMOSAS operate?
PHARMACIE DES MIMOSAS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart